Bacterial endocarditis is a serious and potentially life-threatening infection of the inner lining of the heart chambers (endocardium) or heart valves. It occurs when bacteria enter the bloodstream and attach to damaged areas of the heart, forming infective masses known as vegetations. Common causative bacteria include Streptococcus and Staphylococcus species. Individuals with pre-existing heart conditions, such as damaged heart valves or congenital heart defects, are at an increased risk of developing bacterial endocarditis. The condition often presents with symptoms like fever, fatigue, chills, and heart murmurs. Diagnosis involves blood cultures and imaging studies like echocardiography. Bacterial endocarditis requires prompt and targeted antibiotic treatment to eliminate the infecting bacteria. In severe cases or when complications arise, surgical intervention may be necessary to repair or replace damaged heart valves. Preventive measures involve antibiotic prophylaxis before certain dental or medical procedures in individuals with high-risk conditions. However, recommendations for prophylaxis have evolved, and the decision is often based on individual patient factors. Timely diagnosis and appropriate management are crucial to improving outcomes and reducing the risk of complications associated with bacterial endocarditis.
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria